News
Mangalam Drugs and Organics reports consolidated net loss of Rs 9.84 crore in the December 2025 quarter
15-Jan-2026 | 18:21
Sales decline 34.07% to Rs 58.38 crore
Net loss of Mangalam Drugs and Organics reported to Rs 9.84 crore in the quarter ended December 2025 as against net profit of Rs 1.29 crore during the previous quarter ended December 2024. Sales declined 34.07% to Rs 58.38 crore in the quarter ended December 2025 as against Rs 88.55 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 58.38 | 88.55 | -34 |
| OPM % | -2.45 | 9.90 | - |
| PBDT | -5.37 | 5.42 | PL |
| PBT | -9.84 | 1.37 | PL |
| NP | -9.84 | 1.29 | PL |
Powered by Capital Market - Live News